We are live on ! Find out more
EVGN icon

Evogene
EVGN

16 hedge funds and large institutions have $167K invested in Evogene in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0% more funds holding

Funds holding: 16 → 16 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

4.36% less ownership

Funds ownership: 6.32% → 1.96% (-4.4%)

68% less capital invested

Capital invested by funds: $527K → $167K (-$360K)

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$39.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$26.1K
3
TSS
Two Sigma Securities
New York
+$9.21K
4
Bank of America
Bank of America
North Carolina
+$2.92K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$1.59K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$395K
2
Jane Street
Jane Street
New York
-$22.9K
3
UBS Group
UBS Group
Switzerland
-$14.7K
4
XT
XTX Topco
Cayman Islands
-$12.9K
5
JP Morgan Chase
JP Morgan Chase
New York
-$114
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$41K +$39.2K +32,017 New
Citadel Advisors
2
Citadel Advisors
Florida
$27.4K +$26.1K +21,369 New
TSS
3
Two Sigma Securities
New York
$27K +$9.21K +7,527 +56%
Morgan Stanley
4
Morgan Stanley
New York
$19.4K +$734 +600 +4%
Jane Street
5
Jane Street
New York
$19.2K -$22.9K -18,709 -55%
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$18.1K +$1.59K +1,300 +10%
UBS Group
7
UBS Group
Switzerland
$8.61K -$14.7K -12,016 -64%
Bank of America
8
Bank of America
North Carolina
$3.16K +$2.92K +2,387 +2,842%
SS
9
SBI Securities
Japan
$856 +$730 +597 +829%
SPIA
10
Steward Partners Investment Advisory
New York
$646 – – –
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$640 – – –
TCM
12
Tradewinds Capital Management
Washington
$384 +$367 +300 New
Raymond James Financial
13
Raymond James Financial
Florida
$256 +$245 +200 New
Osaic Holdings
14
Osaic Holdings
Arizona
$244 – – –
US Bancorp
15
US Bancorp
Minnesota
$19 – – –
AC
16
Armistice Capital
New York
– -$395K -316,024 Closed
XT
17
XTX Topco
Cayman Islands
– -$12.9K -10,179 Closed
JP Morgan Chase
18
JP Morgan Chase
New York
– -$114 -200 Closed
T
19
Tidemark
California
– -$38 -30 Closed

EVGN Hedge Fund Activity: Q2 2025 in Review

16 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q2 2025, worth a combined $167K — down 68% from $527K a quarter earlier.

Fund positioning in EVGN was balanced in Q2 2025: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $39.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $395K sold.

  • 16 institutional investors held Evogene (EVGN) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $167K of Evogene stock for Q2 2025, down 68% quarter-over-quarter.
  • 4 funds opened new Evogene positions in Q2 2025 and 4 closed out, a net change of 0 holders.
  • The largest Evogene buyer in Q2 2025 was Virtu Financial, an estimated $39.2K added.
  • The largest Evogene seller in Q2 2025 was Armistice Capital, an estimated $395K sold.

Based on aggregated 13F filings for Q2 2025.